Professor Michael Stowasser
Professor Stowasser has over 25 years clinical research experience in pathogenesis and management of hypertension and especially of endocrine varieties including primary aldosteronism, renovascular hypertension, pheochromocytoma and familial hyperkalemic hypertension. Working with mentor Dr Richard Gordon, he helped to demonstrate that primary aldosteronism is at least 10 times more common than previously thought, and is the commonest specifically treatable and potentially curable form of hypertension. Ongoing studies are aimed at determining genetic bases and pathogenesis of primary aldosteronism, examining non-blood pressure dependent effects of aldosterone excess, improving methods of detection, diagnostic workup and management of primary aldosteronism and exploring the pathogenesis and genetics of other salt sensitive forms of hypertension. Michael was chosen to serve on an international Task Force to develop the first international guideline for the diagnosis of primary aldosteronism. He is currently President of the High Blood Pressure Research Council of Australia and Editor-in-Chief of the Journal of Human Hypertension.
PositionsDirector, Endocrine Hypertension Research Centre, Greenslopes and Princess Alexandra Hospitals
Director, Hypertension Unit, PAH